Australia markets closed

Edgewise Therapeutics, Inc. (EWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
18.01+0.51 (+2.91%)
At close: 04:00PM EDT
18.05 +0.04 (+0.22%)
After hours: 06:02PM EDT

Insider transactions

Currency in USD
Insider purchases - Last 6 monthsSharesTrans
Purchases1,080,59111
Sales144,0769
Net shares purchased (sold)936,51520
Total insider shares held439.91kN/A
% net shares purchased (sold)-188.60%N/A
Net institutional purchases - Prior quarter to latest quarterShares
Net shares purchased (sold)N/A
% change in institutional shares heldN/A

Insider transactions reported - last two years

InsiderTransactionTypeValueDateShares

CARRUTHERS R MICHAEL
Chief Financial Officer

Sale at price 18.91 per share.Direct40,78902 May 20242,157

KOCH KEVIN
Chief Executive Officer

Sale at price 18.91 per share.Direct59,60402 May 20243,152

MOORE JOHN R
General Counsel

Sale at price 18.91 per share.Direct36,98802 May 20241,956

DONOVAN JOANNE M
Officer

Sale at price 18.91 per share.Direct69,62702 May 20243,682

DERAKHSHAN BEHRAD
Officer

Sale at price 18.91 per share.Direct32,48702 May 20241,718

RUSSELL ALAN J
Officer and Director

Sale at price 18.91 per share.Direct29,80202 May 20241,576

CARRUTHERS R MICHAEL
Chief Financial Officer

Direct01 May 20245,208

KOCH KEVIN
Chief Executive Officer

Direct01 May 202410,417

MOORE JOHN R
General Counsel

Direct01 May 20245,208

DONOVAN JOANNE M
Officer

Direct01 May 202410,417

DERAKHSHAN BEHRAD
Officer

Direct01 May 20245,208

RUSSELL ALAN J
Officer and Director

Direct01 May 20245,208

MOORE JOHN R
General Counsel

Sale at price 20.00 - 20.01 per share.Direct596,80509 Feb 202429,835

MOORE JOHN R
General Counsel

Conversion of Exercise of derivative security at price 1.93 per share.Direct57,58209 Feb 202429,835

DERAKHSHAN BEHRAD
Officer

Sale at price 20.00 - 20.04 per share.Direct200,25809 Feb 202410,000

DERAKHSHAN BEHRAD
Officer

Conversion of Exercise of derivative security at price 1.93 per share.Direct19,30009 Feb 202410,000

CARRUTHERS R MICHAEL
Chief Financial Officer

Sale at price 15.78 per share.Direct1,419,75923 Jan 202490,000

CARRUTHERS R MICHAEL
Chief Financial Officer

Conversion of Exercise of derivative security at price 1.93 per share.Direct173,70023 Jan 202490,000

THOMPSON PETER A
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 15.46 per share.Indirect7,027,26623 Jan 2024454,545

ORBIMED ADVISORS, L.L.C.
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 15.46 per share.Indirect7,027,26623 Jan 2024454,545

MOORE JOHN R
General Counsel

Sale at price 10.50 per share.Direct89,21827 Dec 20238,497

FOX JONATHAN C
Director

Purchase at price 9.30 per share.Direct100,95826 Dec 202310,857

RUSSELL ALAN J
Officer and Director

Sale at price 9.33 per share.Direct1,610,09726 Dec 2023172,585

CARRUTHERS R MICHAEL
Chief Financial Officer

Conversion of Exercise of derivative security at price 0.71 per share.Direct7,10022 June 202310,000

CARRUTHERS R MICHAEL
Chief Financial Officer

Sale at price 8.90 per share.Direct11,89702 May 20231,336

KOCH KEVIN
Chief Executive Officer

Sale at price 8.90 per share.Direct28,52202 May 20233,203

MOORE JOHN R
General Counsel

Sale at price 8.90 per share.Direct16,89302 May 20231,897

DONOVAN JOANNE M
Officer

Sale at price 8.90 per share.Direct28,97702 May 20233,254

DERAKHSHAN BEHRAD
Officer

Sale at price 8.90 per share.Direct15,55702 May 20231,747

RUSSELL ALAN J
Officer and Director

Sale at price 8.90 per share.Direct14,26602 May 20231,602

CARRUTHERS R MICHAEL
Chief Financial Officer

Direct01 May 20235,208

KOCH KEVIN
Chief Executive Officer

Direct01 May 202310,416

MOORE JOHN R
General Counsel

Direct01 May 20235,208

DONOVAN JOANNE M
Officer

Direct01 May 202310,416

DERAKHSHAN BEHRAD
Officer

Direct01 May 20235,208

RUSSELL ALAN J
Officer and Director

Direct01 May 20235,208

MOORE JOHN R
General Counsel

Sale at price 9.76 per share.Direct46,15503 Oct 20224,730

MOORE JOHN R
General Counsel

Conversion of Exercise of derivative security at price 1.93 per share.Direct9,12903 Oct 20224,730

THOMPSON PETER A
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 10.32 per share.Indirect4,999,99916 Sept 2022484,496

ORBIMED ADVISORS, L.L.C.
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 10.32 per share.Indirect4,999,99916 Sept 2022484,496

NOVO HOLDINGS A/S
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 10.32 per share.Direct4,999,99914 Sept 2022484,496

MOORE JOHN R
General Counsel

Sale at price 10.83 - 10.99 per share.Direct51,59806 Sept 20224,730

MOORE JOHN R
General Counsel

Conversion of Exercise of derivative security at price 1.93 per share.Direct9,12906 Sept 20224,730

MOORE JOHN R
General Counsel

Sale at price 9.31 per share.Direct85,92103 Aug 20229,232

MOORE JOHN R
General Counsel

Conversion of Exercise of derivative security at price 0.71 - 1.93 per share.Direct12,32503 Aug 20229,232

MOORE JOHN R
General Counsel

Sale at price 8.35 - 8.54 per share.Direct77,25606 July 20229,232

MOORE JOHN R
General Counsel

Conversion of Exercise of derivative security at price 0.71 - 1.93 per share.Direct12,32506 July 20229,232

MOORE JOHN R
General Counsel

Sale at price 6.17 - 7.29 per share.Direct463,93521 June 202267,927

MOORE JOHN R
General Counsel

Conversion of Exercise of derivative security at price 0.71 - 1.93 per share.Direct114,61921 June 202267,927

MOORE JOHN R
General Counsel

Sale at price 6.01 - 6.11 per share.Direct160,45715 June 202226,381

MOORE JOHN R
General Counsel

Conversion of Exercise of derivative security at price 0.71 - 1.93 per share.Direct19,44415 June 202226,381

MOORE JOHN R
General Counsel

Sale at price 6.05 - 6.63 per share.Direct175,87810 June 202227,306

MOORE JOHN R
General Counsel

Conversion of Exercise of derivative security at price 0.71 per share.Direct19,38710 June 202227,306

MOORE JOHN R
General Counsel

Sale at price 6.03 - 6.61 per share.Direct295,98507 June 202247,287

MOORE JOHN R
General Counsel

Conversion of Exercise of derivative security at price 0.71 - 1.93 per share.Direct70,34107 June 202247,287

CARRUTHERS R MICHAEL
Chief Financial Officer

Conversion of Exercise of derivative security at price 0.71 per share.Direct6,39023 May 20229,000

THOMPSON PETER A
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 7.21 per share.Indirect994,98018 May 2022138,000

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 7.21 per share.Indirect994,98018 May 2022138,000

MOORE JOHN R
General Counsel

Sale at price 7.42 per share.Direct80,14616 May 202210,800

MOORE JOHN R
General Counsel

Conversion of Exercise of derivative security at price 0.71 per share.Direct3,83421 Jan 20225,400

MOORE JOHN R
General Counsel

Conversion of Exercise of derivative security at price 0.71 per share.Direct3,83428 Dec 20215,400

RUSSELL ALAN J
Officer

Conversion of Exercise of derivative security at price 0.18 - 0.45 per share.Direct37,81530 Nov 2021172,585

RUSSELL ALAN J
Officer and Director

Sale at price 19.07 - 19.61 per share.Direct9,15515 Nov 2021479

RUSSELL ALAN J
Officer

Sale at price 19.51 - 20.43 per share.Direct1,388,78812 Nov 202169,740

RUSSELL ALAN J
Officer and Director

Sale at price 19.62 - 20.70 per share.Direct583,82308 Nov 202129,451

RUSSELL ALAN J
Officer and Director

Sale at price 17.43 - 19.42 per share.Direct789,90903 Nov 202144,172

RUSSELL ALAN J
Officer and Director

Sale at price 18.00 - 18.18 per share.Direct130,48315 Oct 20217,182

RUSSELL ALAN J
Officer and Director

Sale at price 18.02 per share.Direct22,88511 Oct 20211,270

RUSSELL ALAN J
Other Executive

Sale at price 18.03 - 18.56 per share.Direct386,74308 Oct 202121,028

RUSSELL ALAN J
Officer

Sale at price 18.00 - 18.26 per share.Direct105,40905 Oct 20215,778

RUSSELL ALAN J
Officer and Director

Sale at price 16.83 - 17.47 per share.Direct452,48329 Sept 202126,454

RUSSELL ALAN J
Officer and Director

Sale at price 17.98 - 19.42 per share.Direct1,071,42227 Sept 202158,546

ROOT JONATHAN D
Director

Purchase at price 31.22 per share.Direct487,81230 Mar 202115,625

ROOT JONATHAN D
Director

Indirect30 Mar 20213,473,543

FLYNN JAMES E
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 31.22 per share.Indirect19,512,50030 Mar 2021625,000

FLYNN JAMES E
Beneficial Owner of more than 10% of a Class of Security

Indirect30 Mar 20213,308,137

THOMPSON PETER A
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 31.22 per share.Indirect11,219,68830 Mar 2021359,375

THOMPSON PETER A
Director and Beneficial Owner of more than 10% of a Class of Security

Indirect30 Mar 202113,002,760

NOVO HOLDINGS A/S
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 31.22 per share.Direct19,512,50030 Mar 2021625,000

NOVO HOLDINGS A/S
Beneficial Owner of more than 10% of a Class of Security

Direct30 Mar 20214,962,207

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 31.22 per share.Indirect11,219,68830 Mar 2021359,375

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Indirect30 Mar 202113,002,760

WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS CAYMAN I L
Beneficial Owner of more than 10% of a Class of Security

Direct30 Mar 2021681,812